News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
200 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (205)
2 (212)
3 (281)
4 (278)
5 (122)
6 (5)
7 (3)
8 (167)
9 (263)
10 (216)
11 (235)
12 (115)
13 (3)
14 (9)
15 (240)
16 (261)
17 (192)
18 (222)
19 (132)
20 (17)
21 (46)
22 (200)
23 (295)
24 (242)
25 (259)
26 (121)
27 (8)
28 (12)
29 (232)
30 (334)
31 (209)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Career Advice
Grace Under Fire: How to Respond to Tough Job Interview Questions
It’s one of the biggest sources of anxiety when you’re on the job market: being faced with tough interview questions that you aren’t quite sure how to answer.
October 22, 2018
·
3 min read
·
Editorial Staff
Business
Cc develops the brand Joyn Bio for the newly formed joint venture of Ginkgo Bioworks and Leaps by Bayer
Brand, name, CI and website for Joyn Bio created by Cc – Circle Culture Consulting. The core task consisted of finding the appropriate visual language to communicate the innovations of the new synthetic biology company.
October 22, 2018
·
2 min read
STERNA BIOLOGICALS TO ATTEND BIO-EUROPE® 2018 24th ANNUAL INTERNATIONAL PARTNERING CONFERENCE
Sterna biologicals GmbH & Co. KG today announced that the Company will participate in the upcoming BIO-Europe® 2018 – 24th Annual International Partnering Conference taking place from November 5 to 7, 2018 in Copenhagen, Denmark.
October 22, 2018
·
2 min read
Pharm Country
Healthy Lung Month: Emerging Treatment Options for Mesothelioma Patients
Mesothelioma is a rare cancer that develops in the lining of the lungs, abdomen, or cardiovascular cavity. A 2017 study reported that the number of people affected by this rare cancer is between 2,400 - 2,800 individuals per year in the United States alone.
October 22, 2018
·
7 min read
·
Emily Walsh, Mesothelioma Cancer Alliance
Secarna Pharmaceuticals to attend BIO-Europe® 2018 - 24th Annual International Partnering Conference
Secarna Pharmaceuticals today announced that the Company will participate in the upcoming BIO-Europe®2018 – 24th Annual International Partnering Conference taking place from November 5 to 7, 2018 in Copenhagen, Denmark.
October 22, 2018
·
2 min read
BioCapital
SCRS Announces SPRIA and Site Tank Winners
The Society for Clinical Research Sites (SCRS) announced to almost 1,000 attendees at their 2018 Global Site Solutions Summit that Chattanooga Medical Research and Envision Physical Clinical Research are the respective winners of the Site Patient Recruitment Innovation Achievement (SPRIA) Award and the Site Tank Award.
October 22, 2018
·
2 min read
Drug Development
Updated with Exclusive | ESMO 2018: 60% of Ovarian Cancer Patients Receiving Lynparza Were Progression-Free at 3 Years
AstraZeneca and Merck & Co. presented results at the Presidential Symposium at the European Society for Medical Oncology 2018 Congress held in Munich Germany describing its Phase III SOLO-1 trial of Lynparza (olaparib) in ovarian cancer.
October 22, 2018
·
4 min read
·
Mark Terry
Drug Development
Auris Medical Announces Positive Results From Second Phase 1 Clinical Trial With Intranasal Betahistine
Bioavailability significantly higher than with oral administration
October 22, 2018
·
6 min read
Business
Department of Defense Amyotrophic Lateral Sclerosis Research Program
Anticipated Funding Opportunities for Fiscal Year 2019 (FY19)
October 22, 2018
·
4 min read
Oventus Medical Ltd (ASX:OVN) New Clinical Trial Data Demonstrates Sleep Treatment Platform Delivers Significantly Improved Treatment Outcomes for OSA Sufferers
Oventus Medical Ltd is pleased to announce that new clinical data from four separate studies on its Sleep Treatment Platform will be presented at Sleep DownUnder, the 30th annual meeting of sleep specialists, taking place in Brisbane between 17th -20th October.
October 22, 2018
·
3 min read
1 of 20
Next
